AbbVie has unveiled the first data from its $350 million obesity bet, with the amylin analog demonstrating weight loss of close to 10% after 12 weeks in one dose cohort.

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

After sponsoring three highly successful weight-loss challenges within the trucking industry, with more than 7,600 pounds lost, the Truckload Carriers Association has now added a 30-week maintenance ...

I approached my weight loss as a lifestyle change, adjusting my habits, exercise routine, and diet in a way that felt ...